HM Hospitales

What HM Hospitales does

HM Hospitales is a private, family-owned hospital group headquartered in Madrid, Spain, founded in 1989 and operating one of the country's largest private healthcare networks. The group runs 17 hospitals, 31 polyclinics, 38 specialized centers, and 5 major integral centers spanning oncology (Centro Integral Oncológico Clara Campal HM CIOCC), cardiovascular disease (HM CIEC), and neuroscience (HM CINAC), supported by 7,500 medical professionals. Services span primary through tertiary care, with additional specialty lines in fertility, dental, ophthalmology, maternal-infant care, robotic surgery, preventive check-ups, second medical opinions, and clinical trials. The group serves Spanish residents seeking private alternatives to the public system as well as international patients, students, and diplomatic corps through a dedicated International Patient service backed by two dedicated legal entities.

The company's revenue model is predominantly fee-for-service healthcare delivery - hospital admissions, outpatient consultations, diagnostic tests, surgeries, and treatments - supplemented by insurance partnership income and dedicated international patient coordination. HM Hospitales has built proprietary digital infrastructure including the Portal del Paciente (web and mobile, available on iOS and Android) with a family 'Mi Círculo' feature, AI-assisted diagnostic and treatment tools, an AI-powered digital pathology solution covering 19 cancer types, and robotic surgery. In March 2026 the group co-launched Europe's first Global Smart Healthcare Showcase with Huawei at MWC Barcelona, integrating Wi-Fi 7, CloudCampus, CampusInsight, all-flash storage, and a medical data lake to support hospital information systems (HIS), PACS, and intelligent quality control in medical imaging and pathology.

Ownership remains with the Abarca Cidón family, with Alejandro Abarca serving as CEO and Juan Abarca Cidon as President. The group reported FY2025 revenue of €806.4 million, a 9.9% year-over-year increase and its highest growth rate in six years, with management guiding to approach €900 million in FY2026. HM Hospitales holds a Top 3 corporate reputation ranking in Spain (Merco Empresas 2025) and a layered compliance stack including ISO 27001, ENS, TÜV Rheinland quality and safety, EFQM 700 Seal, IDIS Excelencia en Calidad Asistencial, and Madrid Excelente. Recent strategic activity includes the integration of Grup Creu Groga in Catalonia (June 2026), an organoid research agreement with Princess Máxima Center and Hubrecht Institute (May 2026), and a pediatric onco-hematology clinical research unit with START Center (October 2025).

Name

HM Hospitales

Legal name

PROFESIONALES DE LA MEDICINA Y DE LA EMPRESA, S.A.

Website

https://hmhospitales.com

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

HM Hospitales is a private, family-owned Spanish hospital group operating 17 hospitals, 31 polyclinics, and 38 specialized centers. Headquartered in Madrid and founded in 1989, the group serves domestic and international patients through advanced specialty, AI-assisted, and research-driven care, generating €806.4 million in 2025 revenue.

Ownership category

akta.pro rank

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices17 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Healthcare Services Revenue: HM Hospitales generates revenue primarily through providing private healthcare services including hospital admissions, outpatient consultations, diagnostic tests, surgeries, and specialized treatments at its hospital and polyclinic network across Spain.
2. Insurance and Mutual Partnerships: Revenue from partnerships with insurance companies and mutual insurance providers for patient care coverage, including verification, validation and control of payment for services rendered.
3. International Patient Services: Specialized services for international patients including translation, documentation management, and personalized 24/7 attention, generating revenue from non-resident patients, students, and diplomatic corps.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

HM Hospitales is a Spanish private hospital group that operates 17 hospitals, 31 polyclinics, and 38 specialized integral centers delivering comprehensive private healthcare services — including prevention, diagnostics, surgery, oncology, cardiology, neuroscience, fertility, dental, and ophthalmology care — alongside clinical research and teaching-hospital programs through its foundation.

Product overview

HM Hospitales operates as a unified hospital network platform offering comprehensive healthcare services through 17 hospitals and multiple specialized centers across Spain. The portfolio is organized around three integrated cancer, cardiovascular, and neuroscience centers (CIOCC, CIEC, CINAC), supplemented by specialized centers for fertility, dental, and eye care. Digital services include the Portal del Paciente web and mobile app for patient engagement, HM+ premium care services, laboratory services (HM Labs), robotic surgery, and clinical trials. The group also provides preventive health check-ups, second medical opinions, international patient services, and operates its own research foundation and medical education institute. Recent innovation includes the Global Smart Healthcare Showcase developed with Huawei showcasing AI-powered diagnostic and pathology solutions.

Differentiator

Problem solved

Functional benefit

Brands

• HM+: Premium personalized health service with dedicated personal assistant for health management
• HM CIOCC
• HM CINAC
• HM CIEC
• HM Fertility Center
• HM Dental Center
• HM Eye Center
• International Patient
• Mi Portal HM

Products and services

• Private Hospital Healthcare Services Comprehensive private hospital care delivered across the group's 17 hospitals, covering prevention, diagnostics, hospitalization, emergency, and general medical-surgical treatment for individual patients in Spain.
• HM CIOCC (Centro Integral Oncológico Clara Campal) Specialized integral oncology center providing comprehensive cancer diagnosis, treatment, and research services to oncology patients referred across the HM Hospitales network.
• HM CIEC (Centro Integral de Enfermedades Cardiovasculares) Specialized integral cardiology center providing advanced cardiovascular diagnosis, interventional treatment, and cardiac surgery within the HM Hospitales network.
• HM CINAC (Centro Integral de Neurociencias AC) Specialized integral neuroscience center focused on advanced diagnosis and treatment of neurological disorders for patients within the HM network.
• HM Fertility Center Specialty fertility and reproductive medicine services for individuals and couples seeking assisted reproduction treatment.
• HM Dental Center Dental care services offered through dedicated centers within the HM Hospitales network.
• HM Eye Center Ophthalmology services delivered through dedicated eye centers within the HM Hospitales network.
• HM Labs Clinical laboratory and diagnostic testing services (including imaging and pathology) supporting the HM Hospitales network and external referrals.
• HM+ Premium Service Premium-tier private healthcare service within HM Hospitales that offers enhanced amenities, priority access, and differentiated patient experience for paying individual members.
• Chequeos HM (Preventive Health Check-ups) Standalone preventive medicine check-up programs for individual patients seeking comprehensive diagnostic health screenings.
• Segunda Opinión Médica (Medical Second Opinion) Standalone second-opinion medical consultation service for patients seeking expert review of an existing diagnosis or treatment plan.
• Cirugía Robótica (Robotic Surgery) Robotic-assisted surgical procedures offered across HM Hospitales for patients who qualify for minimally invasive robotic surgery.
• Ensayos Clínicos (Clinical Trials) Clinical trials program run through HM Hospitales' research foundation, providing patients access to investigational treatments and generating research revenue.
• International Patient Service Dedicated service line for international patients traveling to HM Hospitales for private medical treatment, including coordination and multilingual support.
• HM Hospitales Mobile App Mobile application that allows individual patients to access HM Hospitales services, manage appointments, and interact with the Patient Portal.
• Portal del Paciente (Patient Portal) Online patient portal giving individual patients digital access to HM Hospitales records, appointments, and administrative services.
• Pediatric Onco-Hematology Clinical Research Unit Specialized clinical research unit dedicated to pediatric oncology and hematology clinical trials within the HM Hospitales network.

Quantifiable outcome

• Revenue of 806.4 million euros in 2025, 9.9% year-over-year increase
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Partnerships

Five partnerships are on record, tiered minor, core and flagship.

• Grup Creu GrogaminorStrategic or Co-development Partner · 18 June 2026HM Hospitales reinforced its presence in Catalonia with the integration of Grup Creu Groga into its care network, expanding HM Hospitales' network in Catalonia into the Maresme region.
• Princess Máxima Center for Pediatric OncologycoreStrategic or Co-development Partner · 22 May 2026HM Hospitales signed a strategic international agreement with Princess Máxima Center for Pediatric Oncology and Hubrecht Institute to drive organoid research and personalized medicine. This collaboration advances research in organoids and personalized medicine, combining expertise in pediatric oncology research.
• Hubrecht InstitutecoreStrategic or Co-development Partner · 22 May 2026HM Hospitales signed a strategic international agreement with Hubrecht Institute and Princess Máxima Center to drive organoid research and personalized medicine. The collaboration advances research in organoids and personalized medicine using cutting-edge organoid technology.
• HuaweiflagshipTechnology or Integration · 6 March 2026HM Hospitales and Huawei jointly launched the Global Smart Healthcare Showcase at MWC Barcelona 2026, marking Huawei's first smart healthcare showcase in Europe. The collaboration integrates Huawei's digital technologies including Wi-Fi 7 infrastructure, cloud campus management, flash storage, and medical data lake platforms with HM Hospitales' clinical operations to advance smart hospital capabilities across medical imaging, pathology, and campus management. This collaboration merges Chinese digital technology with European healthcare expertise to create a global model for intelligent healthcare transformation.
• START Center for Cancer ResearchcoreStrategic or Co-development Partner · 14 October 2025START Center for Cancer Research, in collaboration with HM Hospitales, launched Spain's first pediatric onco-hematology clinical research unit at HM Montepríncipe University Hospital in Madrid. The new unit provides clinical trial access for children with cancer and supports all phases of pediatric oncology studies.

Scale indicators10 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Hospitales HLA (ASISA Group): HLA is the hospital network of ASISA, Spain's second-largest health insurer, comprising ~17 hospitals across Spain. It is a directly comparable vertically integrated private hospital-insurer model — same country, similar multi-specialty acute care focus, similar insured-patient revenue mix as HM Hospitales.
• Quironsalud: Quironsalud is the largest private hospital group in Spain, owned by Fresenius Helios, operating 50+ hospitals and a comprehensive specialty and polyclinic footprint. It is the most direct competitor to HM Hospitales — same private acute-care model in Spain, comparable specialty center strategy (oncology, cardiology, women's health, fertility), and overlapping insurance partner channels.
• Clínica Universidad de Navarra (CUN): CUN is a leading Spanish private teaching hospital group with two main campuses (Pamplona and Madrid). It matches HM Hospitales' emphasis on teaching, research, and complex specialty care, and competes for high-acuity private patients, particularly in oncology and neuroscience.
• Ribera Salud Group: Ribera Salud is a Spanish private hospital and healthcare-services group historically associated with the Ribera and Vinalopó models, including public-private partnership arrangements. Comparable to HM Hospitales in private acute care in Spain, with overlapping geographies in Levante and the Valencian Community.
• Vithas: Vithas operates around 20 private hospitals across Spain, with specialties spanning oncology, cardiology, neurology, and fertility. It mirrors HM Hospitales' regional acute-care-plus-specialty model and competes head-to-head for the same insured and self-pay patient pools in overlapping Spanish markets.
• Sanitas Hospitales (Bupa): Sanitas Hospitales is the hospital arm of Bupa Spain, operating private hospitals and specialty centers (including the Hospital Sanitas La Zarzuela and CIMA complexes). It competes with HM Hospitales for insured patients in Madrid, Barcelona, and Valencia, with overlapping technology-enabled care models.

Emerging players

• Hospitales y Centros Health (Grupo DKV / ERGO): DKV operates selective hospital facilities and integrates closely with Munich Re/ERGO health-insurance assets in Spain. Comparable to HM Hospitales' insurance-partnership GTM, though DKV's owned facility footprint is much smaller and primarily used for risk-management rather than scale service provision.

Broad incumbents

• Ramsay Health Care: Ramsay Health Care is a global private hospital operator with facilities across Australia, the UK, France, and the Nordics. Comparable as a private acute-care hospital network with similar bundled specialty services and digital patient initiatives, but operating at materially larger scale and broader geography.
• Fresenius Helios: Fresenius Helios is the European hospital arm of Fresenius and the parent of Quironsalud, operating ~90+ hospitals across Germany and Spain. Comparable to HM Hospitales as a regional acute-care platform, but with vastly larger scale and integrated payer-provider economics.

Regional players

• Grupo Hospitalario Quirón (pre-Quironsalud legacy entities in LATAM/Iberia): Quirónsalud operates across Spain and selectively in LATAM (e.g., Colombia via QuirónSalud La Salud, Eugin). Comparable to HM Hospitales as a private acute-care provider with international patient programs, but with broader geographic diversification beyond Iberia.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/HMHospitales
• YouTubeyoutube.com/@hmhospitales
• Facebookfacebook.com/HMHospitales
• LinkedInlinkedin.com/company/hm-hospitales
• Instagraminstagram.com/hmhospitales

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries29 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HM Hospitales